James Jogerst
Corporate Officer/Principal bei RUBIUS THERAPEUTICS
Profil
James Jogerst is currently the Chief Business Officer at Rubius Therapeutics, Inc. Prior to this, he worked as the Vice President-Corporate Development at Adare Pharma Solutions, Inc. from 2015 to 2017.
Jogerst holds an MBA from Pepperdine University and an undergraduate degree from the University of North Texas.
Aktive Positionen von James Jogerst
| Unternehmen | Position | Beginn |
|---|---|---|
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 30.08.2021 |
Ehemalige bekannte Positionen von James Jogerst
| Unternehmen | Position | Ende |
|---|---|---|
Adare Pharma Solutions, Inc.
 Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von James Jogerst
| Pepperdine University | Masters Business Admin |
| University of North Texas | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
